PLATELET REGULATION OF MONOKINE SYNTHESIS
单因子合成的血小板调节
基本信息
- 批准号:2702333
- 负责人:
- 金额:$ 10.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2001-04-30
- 项目状态:已结题
- 来源:
- 关键词:T lymphocyte atherosclerotic plaque biological signal transduction chemokine clinical research enzyme activity human subject immunoregulation inflammation interleukin 8 monocyte chemoattractant protein 1 monokines nuclear factor kappa beta platelet activation protein biosynthesis protein kinase selectins tumor necrosis factor alpha
项目摘要
DESCRIPTION: The long term goal of this project is to understand how
platelets regulate monocyte function. This issue is particularly
important since platelets interact with monocytes in a variety of
atherosclerotic disorders. The applicant recently demonstrated that
activated platelets, but not unstimulated platelets, induce immediate-
early (IE) gene expression in monocytes. Among the IE genes expressed,
interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) were
synthesized and secreted by monocytes exposed to activated platelets.
Other IE genes, including tumor necrosis factor-2 (TNF-2), were not
generated. Initial results indicate that P-selectin and RANTES
(Regulated upon Activation Normal T Cell Expressed presumed Secreted),
two platelet-derived molecules, are required for both IL-8 and MCP-1
synthesis in monocytes through P-selectin and RANTES. Signaling in
monocytes through P-selectin and RANTES will be compared to signaling
induced by LPS, a potent monocyte agonist. In the first Specific Aim,
the applicant will further characterize how P-selectin and RANTES
regulate monokine synthesis. These studies will initially be defined
in a reduced system where different forms of purified P-selectin and
RANTES are presented to monocytes; and cellular MRNA, cellular retained
protein, and secreted protein for IL-8, MCP-1, and TNF-2 will be
measured. A more complex system involving platelet-monocyte
interactions to determine if P-selectin and RANTES are required for
monokine production will be examined. Specific Aim 3 will determine
if P-selectin and RANTES regulate NF-kappaB activity in monocytes. NF-
kappaB is a transcription factor that is required for maximal IL-8,
MCP-1, and TNF-2 synthesis, and initial results developed by the
applicant indicate that NF-kappaB, and its inhibitory factor IkappaB-2,
are activated by P-selectin and RANTES. The third Specific Aim will
determine if P-selectin and RANTES regulate p70 S6 kinase activity in
monocytes. p70 S6 kinase is known to translationally regulate many
proteins and other evidence also indicates that p70 S6 kinase can
regulate NF-kappaB family members. Initial results suggest that p70 S6
kinase activity is increased in monocytes following exposure to P-
selectin and RANTES or activated platelets. Moreover, inhibition of p70
S6 kinase activity by rapamycin attenuates MCP-1 secretion by monocytes
exposed to activated platelets. In the final Specific Aim, correlative
studies to determine if P-selectin and RANTES are localized in ruptured
carotid arterial plaques will be coordinated. Together, these results
will begin defining how activated platelets, through P-selectin and
RANTES, induce monokine synthesis.
描述:本项目的长期目标是了解如何
血小板调节单核细胞功能。 这个问题尤其
这一点很重要,因为血小板与单核细胞在多种
动脉粥样硬化性疾病申请人最近证明,
激活的血小板,而不是未受刺激的血小板,诱导立即-
单核细胞中的早期(IE)基因表达。 在表达的IE基因中,
白细胞介素-8(IL-8)和单核细胞趋化蛋白-1(MCP-1),
由暴露于活化血小板的单核细胞合成和分泌。
其他IE基因,包括肿瘤坏死因子-2(TNF-2),
生成的. 初步结果表明,P-选择素和RANTES
(活化后调节正常T细胞表达假定分泌),
IL-8和MCP-1都需要两种血小板衍生分子
通过P-选择素和RANTES在单核细胞中合成。信令
单核细胞通过P-选择素和RANTES将比较信号转导
由LPS诱导,一种有效的单核细胞激动剂。在第一个具体目标中,
申请人将进一步表征P-选择素和RANTES
调节单核因子的合成。这些研究最初将被定义为
在还原系统中,不同形式的纯化P-选择素和
RANTES被呈递给单核细胞;而细胞mRNA、细胞内滞留的
蛋白质,以及IL-8、MCP-1和TNF-2的分泌蛋白质将被
测定了 涉及血小板-单核细胞的更复杂的系统
相互作用,以确定是否需要P-选择素和RANTES
将检测单核因子的产生。 第3章将决定
如果P-选择素和RANTES调节单核细胞中NF-κ B活性。 NF-
κ B是最大IL-8所需的转录因子,
MCP-1和TNF-2的合成,以及
申请人指出,NF-κ B及其抑制因子I κ B-2,
被P-选择素和RANTES激活。 第三个具体目标将
确定P-选择素和RANTES是否调节p70 S6激酶活性,
单核细胞 已知p70 S6激酶对多种细胞因子的表达具有抑制性调节作用,
蛋白质和其他证据也表明,p70 S6激酶可以
调节NF-κ B家族成员。初步结果表明,p70 S6
在暴露于P-
选择素和RANTES或活化血小板。 此外,抑制p70
雷帕霉素引起的S6激酶活性减弱单核细胞分泌MCP-1
暴露在活化的血小板中 在最后的具体目标,相关
研究以确定P-选择素和RANTES是否位于破裂的
协调颈动脉斑块。 这些结果一起
将开始定义如何激活血小板,通过P-选择素和
RANTES,诱导单核因子合成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew S Weyrich其他文献
DECREASED TRANSENDOTHELIAL CELL MIGRATION IN NEONATES IS ASSOCIATED WITH DELAYED EXPRESSION OF P-SELECTION. ▴ 1754
- DOI:
10.1203/00006450-199604001-01778 - 发表时间:
1996-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Michael K Garyer;Andrew S Weyrich;Wenhua Li;Diane E Lorant - 通讯作者:
Diane E Lorant
Andrew S Weyrich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew S Weyrich', 18)}}的其他基金
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
- 批准号:
10616557 - 财政年份:2019
- 资助金额:
$ 10.1万 - 项目类别:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
- 批准号:
10569253 - 财政年份:2019
- 资助金额:
$ 10.1万 - 项目类别:
2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
2014止血戈登研究会议暨戈登研究研讨会
- 批准号:
8784662 - 财政年份:2014
- 资助金额:
$ 10.1万 - 项目类别:
Platelet Reprogramming in Human Obesity and Diabetes
人类肥胖和糖尿病中的血小板重编程
- 批准号:
8464247 - 财政年份:2013
- 资助金额:
$ 10.1万 - 项目类别:
Platelet Reprogramming in Human Obesity and Diabetes
人类肥胖和糖尿病中的血小板重编程
- 批准号:
8391959 - 财政年份:2012
- 资助金额:
$ 10.1万 - 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
- 批准号:
8464229 - 财政年份:2012
- 资助金额:
$ 10.1万 - 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
- 批准号:
9068226 - 财政年份:2012
- 资助金额:
$ 10.1万 - 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
- 批准号:
8656415 - 财政年份:2012
- 资助金额:
$ 10.1万 - 项目类别:
相似海外基金
Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
- 批准号:
494557 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
Operating Grants
Endothelial cells communicate with surrounding vascular cells via bidirectional and polarized secretion of extracellular vesicular cargo: Implications for atherosclerotic plaque development.
内皮细胞通过细胞外囊泡货物的双向和极化分泌与周围血管细胞通信:对动脉粥样硬化斑块发展的影响。
- 批准号:
480706 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
Ultrafast analysis of atherosclerotic plaque stress using in vivo imaging, computational modelling and machine learning for more accurate coronary art
使用体内成像、计算建模和机器学习对动脉粥样硬化斑块应力进行超快速分析,以实现更准确的冠状动脉艺术
- 批准号:
2868450 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
Studentship
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
平滑肌细胞衍生的细胞命运和细胞相互作用在疾病进展和消退中动脉粥样硬化斑块的稳定性。
- 批准号:
10567844 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk
鉴定导致动脉粥样硬化斑块稳定性和心血管疾病风险的平滑肌细胞基因
- 批准号:
10720225 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
Endothelial Cell Respiration in Atherosclerotic Plaque Erosion
动脉粥样硬化斑块糜烂中的内皮细胞呼吸
- 批准号:
10586227 - 财政年份:2023
- 资助金额:
$ 10.1万 - 项目类别:
High Framerate Plane-Wave Variance of Acceleration and Vector Flow Imaging for the Characterization of Atherosclerotic Plaque Morphology and Assessment of Vascular Hemodynamics
高帧率平面波加速度方差和矢量流成像用于动脉粥样硬化斑块形态的表征和血管血流动力学的评估
- 批准号:
10461534 - 财政年份:2022
- 资助金额:
$ 10.1万 - 项目类别:
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
研究 2019 年冠状病毒病 (COVID-19) 感染是否加速动脉粥样硬化斑块进展的机制登记
- 批准号:
10482402 - 财政年份:2022
- 资助金额:
$ 10.1万 - 项目类别:
High Framerate Plane-Wave Variance of Acceleration and Vector Flow Imaging for the Characterization of Atherosclerotic Plaque Morphology and Assessment of Vascular Hemodynamics
高帧率平面波加速度方差和矢量流成像用于动脉粥样硬化斑块形态的表征和血管血流动力学的评估
- 批准号:
10700833 - 财政年份:2022
- 资助金额:
$ 10.1万 - 项目类别:














{{item.name}}会员




